Skip to content
Drug recall · FDA · Published May 9, 2023

B. Braun Medical Inc recalls Heparin Sodium, 25,000 USP units per 250mL, (100 USP units per mL) in 5% Dextrose injection, 250 ml Excel Container, B.

B. Braun Medical recalls heparin sodium injections with low anti-factor IIa potency. This may cause ineffective blood clotting. Affected products have specific lot numbers and expiration dates.

🇺🇸 FDA recall #D-0579-2023DrugB. Braun Medical ›
Take action

Contact the company & request your remedy

Recalling firmB. Braun Medical Inc2525 Mcgaw Ave, N/A · Irvine, CA 92614-5841
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

B. Braun Medical is recalling heparin sodium injections that may have low anti-factor IIa potency. This could lead to ineffective blood clotting if used in medical treatments. Read more at govinfonow.com/recall/33493-b-braun-medical-heparin-injection-recall-subpotent-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/33493-b-braun-medical-heparin-injection-recall-subpotent-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0579-2023

Cite this page

“B. Braun Medical Heparin Injection Recall: Subpotent Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33493-b-braun-medical-heparin-injection-recall-subpotent-risk. Based on FDA recall #D-0579-2023 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0579-2023%22&limit=1).

Why it’s dangerous

The heparin may have lower than expected potency, meaning it might not work effectively to prevent blood clots. This could lead to complications like blood clots forming in the body if used in medical treatments.

Who’s affected

Healthcare professionals and patients using heparin injections for medical treatments. Those with the specific lot numbers and expiration dates are most at risk.

How to tell if you have this one

Check for the product name: Heparin Sodium, 25,000 USP units per 250mL in 5% Dextrose injection. Look for the lot number J1P154N and expiration date of May 31, 2023.

  • Brand
    B. Braun Medical
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the lot number and expiration date on the product label.

✎ GovInfoNow

Questions people ask

Is this product dangerous?

The heparin may have low anti-factor IIa potency, which could lead to ineffective blood clotting. However, the recall is for specific products with known lot numbers.

What should I do if I have this product?

Check the product label for the lot number J1P154N and expiration date of May 31, 2023. If it matches, contact B. Braun Medical for further instructions.

How can I tell if I have the recalled product?

The product is labeled as Heparin Sodium, 25,000 USP units per 250mL in 5% Dextrose injection with lot number J1P154N and expiration date May 31, 2023.

Take action

Contact B. Braun Medical

We’ve drafted a message you can send B. Braun Medical to request your refund or repair — edit it as you like.

Subject: Recall D-0579-2023 — B. Braun Medical B. Braun Medical

Hello,

I own a B. Braun Medical that is covered by recall D-0579-2023 from B. Braun Medical.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0579-2023 (May 9, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0579-2023 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA